Mille Lacs Band sues drug companies over prescription opioids

The federal lawsuit likely will be consolidated with many other cases in an Ohio courtroom.

October 18, 2019 at 12:00AM
FILE - This Monday, June 17, 2019, file photo shows 5-mg pills of Oxycodone. While the nation's attorneys general debate a legal settlement with Purdue Pharma, the opioid epidemic associated with the company's blockbuster painkiller OxyContin rages on. The drugs still kill tens of thousands of people each year with no end in sight. (AP Photo/Keith Srakocic, File)
The federal lawsuit file by the Mille Lacs Band of Ojibwe names 20 defendants, including manufacturers and distributors. (The Minnesota Star Tribune)

The Mille Lacs Band of Ojibwe on Thursday joined a growing list of plaintiffs that have filed federal lawsuits against a variety of businesses in the pharmaceutical industry seeking damages for what they allege has been deceptive trade practices that led to the opioid crisis.

The lawsuit names 20 defendants, including manufacturers and distributors, alleging that they "flooded the market with false statements designed to persuade both doctors and patients that prescription opioids posed a low risk of addiction. Those claims were false."

The 164-page suit alleges the companies made billions of dollars from the drugs.

The band seeks an injunction barring the defendants from further deceptive trade practices in the marketing of the painkillers, unspecified economic damages to compensate the band for the harm that was done, statutory and civil penalties, interest and attorneys' fees.

The lawsuit, filed in Minneapolis by the law firm Lockridge Grindal Nauen, likely will be swept into a multidistrict litigation case pending in Ohio in the near future. Dozens of cities, counties and unions in Minnesota and elsewhere have filed similar lawsuits.

The defendants in the suit include Teva Pharmaceutical Industries LTD and Teva Pharmaceuticals USA Inc.; Cephalon Inc.; Johnson & Johnson; Janssen Pharmaceuticals Inc., Ortho-McNeil-Janssen Pharmaceuticals Inc. and Janssen Pharmaceutica Inc. (now known as Janssen Pharmaceuticals Inc.); Noramco Inc.; Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.; Allergan PLC (formerly known as Actavis PLS); Watson Pharmaceuticals Inc. (now known as Actavis Inc.), Watson Laboratories Inc., Actavis LLC and Actavis Pharma Inc. (formerly known as Watson Pharma Inc.); Mallinckrodt PLC and Mallinckrodt LLC; McKesson Corp.; Cardinal Health Inc., and AmerisourceBergen Drug Corp.

Dan Browning • 612-673-4493

about the writer

about the writer

Dan Browning

Reporter

Dan Browning has worked as a reporter and editor since 1982. He joined the Star Tribune in 1998 and now covers greater Minnesota. His expertise includes investigative reporting, public records, data analysis and legal affairs.

See More